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Early in postnatal life,mossy fibres (MF), the axons of granule cells in the dentate gyrus, releaseGABAwhich
is depolarizing and excitatory. Synaptic currents undergo spike-time dependent long-term depression
(STD-LTD) regardless of the temporal order of stimulation (pre versus post and viceversa). Here we show
that at P3 but not at P21, STD-LTD, induced by negative pairing, is mediated by endocannabinoids
mobilized from the postsynaptic cell during spiking-induced membrane depolarization. By diffusing
backward, endocannabinoids activate cannabinoid type-1 (CB1) receptors probably expressed onMF. Thus,
STD-LTD was prevented by CB1 receptor antagonists and was absent in CB1-KO mice. Consistent with
these data, in situ hybridization experiments revealed detectable level of CB1mRNA in the granule cell layer
at P3 but not at P21. These results indicate that CB1 receptors are transiently expressed on immature MF
terminals where they counteract the enhanced neuronal excitability induced by the excitatory action of
GABA.
T
he axons of granule cells in the dentate gyrus, the mossy fibres (MFs) provide most of the excitatory drive to
CA3 principal cells and GABAergic interneurons of the hilus and stratum lucidum1. Early in postnatal
development MF release GABA which exerts a depolarizing and excitatory action on target neurons2,3.
Immature MFs are endowed with kainate receptors (KARs) and GABAB receptors, whose activation reduces
GABA release leading in some cases to synapse silencing4,5.
Immature MF-CA3 synapses undergo activity-dependent modifications of synaptic efficacy which are crucial
for learning and memory processes and for the refinement of neuronal circuits. Thus, calcium transients assoc-
iated with giant depolarizing potentials or GDPs, a hallmark of developmental networks, act as coincident
detectors for enhancing synaptic efficacy in an associative manner6. In addition, immature MF-CA3 synapses
exhibit spike time-dependent long-term depression (STD-LTD)7, an associative form of learning crucial for
information coding. STD-LTD occurs regardless of the temporal order of stimulation (pre versus post and
viceversa). However, STD-LTD induced by positive pairing (pre before post) can be switched to STD-long-term
potentiation (LTP) by blocking presynaptic GluK1-containing KARs with selective antagonists, indicating that
KARs activated by ‘ambient’ glutamate control the direction of STD-LTD5. However, in the presence of KAR
antagonists, negative pairing (postsynaptic spiking before MF stimulation) still induces LTD, suggesting that
KARs are not involved in this form of synaptic plasticity. Studies from several brain structures have shown that
STD-LTD is controlled by endocannabinoids, which activate presynaptic CB1 receptors via retrograde signalling
and suppress neurotransmitter release at both excitatory and inhibitory synapses8,9. Here we show that, at
immature MF-CA3 synapses, the persistent weakening of synaptic strength induced by correlating postsynaptic
spiking with presynaptic MF activation involves CB1 signalling. Thus, STD-LTD was prevented by selective CB1
receptor antagonists andwas absent inCB1-KOmice. In addition, CB1-mediated STD-LTD could not be induced
at late developmental stages when MF release glutamate on their targets.
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Results
Single MF-evoked GABAA-mediated postsynaptic currents (GPSCs)
were recorded at 260 mV from P3–P6 CA3 pyramidal cells in the
presence of DNQX (50 mM) and D-AP5 (50 mM) to block AMPA/
kainate and NMDA receptors, respectively. Negative pairing (post
50 ms before pre; Fig. 1A and B) induced in 28/44 neurons (64 %) a
persistent depression of MF-GPSCs (see also7). Thirty minutes after
pairing, the mean peak amplitude of GPSCs (successes plus failures)
obtained in all neurons tested (exhibiting or not LTD) was 64.4 6 3.3
% of pre-pairing values (n544; p,0.001; paired t-test; Fig. 1C and
D). In cells exhibiting LTD (n528), synaptic depression was assoc-
iated with a decrease of successes rate (from 0.63 6 0.05 to 0.39 6
0.04, before and after pairing, respectively; n528; p,0.001; paired t-
test), a decrease in the inverse square value of CV (from 2.98 6 0.68
to 1.12 6 0.25; n528; p,0.001; paired t-test) and an increase in PPR
(from 1.09 6 0.21 to 1.98 6 0.49; n512; p,0.001; paired t-test;
Fig. 1E), indicating a reduction in the probability of GABA release.
To further assess whether STD-LTD results from a reduced GABA
release from MF terminals, we analyzed the coefficient of variation
before and 30 min after the induction of pairing. Normalized plots of
1/CV2 versus mean yielded points lying on or below the diagonal,
further suggesting that the locus of depression is presynaptic10
(Fig. 1D). Postsynaptic spiking (10 spikes at 0.1 Hz) in the absence
of presynaptic stimulation did not modify MF-GPSCs.
The induction of STD-LTD may require postsynaptic calcium
influx through spike-induced membrane depolarization. We tested
this possibility by loading the postsynaptic cell with the calcium
chelator BAPTA (20 mM). BAPTA prevented the induction of
STD-LTD (mean peak amplitude of GPSCs: 95.6 6 5% of controls,
n513; p50.7; paired t-test; Fig. 2), indicating that this form of syn-
aptic plasticity is due to an increased calcium level in the postsynaptic
cell. Calcium influx occurs via voltage-dependent calcium channels
(VDCC) since STD-LTD was completely blocked by nifedipine (10
mM) a VDCC blocker (after pairing, the mean peak amplitude of
GPSCs was 94.9 6 3.1% of controls; n58; p50.1; paired t-test;
Fig. 2).
Our data demonstrate a postsynaptic induction of STD-LTD, but a
presynaptic expression as suggested by the increase in PPR and the
decrease in CV22 of MF-GPSCs. The postsynaptic cell must then
provide a paracrine retrograde signal to the presynaptic neuron.
Possible candidates are endocannabinoids (eCBs), mobilized from
principal neurons and known to mediate several forms of retrograde
short- and long-term presynaptic depression9. Once released, eCBs
diffuse to activate CB1 receptors localized on presynaptic neurons
and inhibit transmitter release.
To determine whether STD-LTD was CB1-dependent, we applied
the selective CB1 antagonist AM251. AM251 (5 mM) per se did
not modify synaptic activity (see Supplementary Fig. S1 online).
However, this compound fully prevented STD-LTD in all cells tested,
indicating the involvement of CB1 receptors. In the presence of
AM251, the peak amplitude of MF-GPSCs was 97.4 6 2.7% of con-
trols (n512; p50.37; paired t-test; Fig. 1C and D). Failure of indu-
cing LTD in a minority of cases (36%) suggests that either
endocannabinoids released from principal cells failed to reach MF
terminals or that some MF terminals do not express CB1 receptors.
In agreement with other studies on different brain structures11–13,
application of AM251 20 min after the induction of STD-LTD did
not modify the amplitude of synaptic responses indicating that the
activation of CB1 receptors is necessary for the induction, but not for
the maintenance of STD-LTD (see Supplementary Fig. S1 online).
To further assess the involvement of CB1 receptors in STD-LTD,
the pairing procedure was applied to CA3 principal cells in
hippocampal slices obtained from P3–P6 CB1-KO mice and WT
littermates. As in rats, negative pairing induced a significant and
Figure 1 | STD-LTD requires the activation of CB1 receptors. (A)
Schematic representation of the experimental design. (B) The stimulation
of granule cells in the dentate gyrus followed the postsynaptic spike by
50 ms. (C)MF-GPSCs evoked before, after pairing, after addition of L-AP4
or L-AP4 plus picrotoxin (PTX), in the absence (Control) or in the
presence of AM251 (each trace is the average of 30–60 trials including
failures). (D) Mean GPSCs amplitude (before and after pairing, arrows at
time 0) is plotted against time. Open circles: control (n544); closed circles:
in the presence of AM251(n512); vertical bars are SEM. (E) Paired-pulse
ratio measured before (Control) and after pairing in neurons exhibiting
LTD (grey STD-D; n512). ***p,0.001. (F) Plot of 1/CV2 versus GPSCs
amplitude measured after LTD induction and normalized to respective
controls. The closed circle indicate the mean (SEM is within the symbols).
Figure 2 | Pairing-induced LTD requires a calcium influx in the
postsynaptic cell via voltage-dependent calcium channels. (A) Averaged
traces of MF-GPSC (30 to 60 trials including failures) evoked before and
20 min after pairing in control, in neurons loaded with intracellular
BAPTA (20 mM) or exposed to nifedipine (10 mM). (B) Pairing-induced
changes in the mean amplitude of MF-GPSCs in control (n544), in cells
loaded with BAPTA (n513) or exposed to nifedipine (black column;
n58).
www.nature.com/scientificreports
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persistent depression of MF-GPSCs. Pooled data from animals
exhibiting (n59; 69 % of cases) or not (n54) LTD are reported in
Fig. 3. After pairing the mean GPSCc amplitude was 57.8 6 4.5% of
control values (p50.003; paired t-test; Fig. 3). In cells exhibiting
LTD, synaptic depression was associated with a decrease in successes
rate (from 0.67 6 0.07 to 0.33 6 0.06, before and after pairing,
respectively; n59; p,0.001; paired t-test) and a decrease in the
inverse square value of CV (from 3.5 6 0.58 to 1.6 6 0.3; n59;
p50.003; paired t-test). In contrast, in CB1-KO mice the pairing
protocol did not cause STD-LTD (mean peak amplitude of GPSCs
101.7 6 4.7% of controls; n510; p50.3; paired t-test; Fig. 3), pro-
viding further evidence that CB1 receptors are involved in STD-LTD.
If STD-LTD is mediated by CB1 receptors, the possibility to block
this form of synaptic plasticity with BAPTA and nifedipine indicates
that secretion of eCBs from principal cells is triggered by the eleva-
tion of intracellular calcium via VDCC. However, signalling via
group I mGluR might also contribute to intracellular calcium rise
via PLC, as described for some forms of eCBs-dependent synaptic
plasticity12,14. Therefore, we tested whether the selective mGluR1 and
mGluR5 antagonists LY 367385 andMPEP, respectively were able to
prevent STD-LTD. Bath application of LY 367385 (100 mM) and
MPEP (5 mM), either alone or in combination, failed to affect
STD-LTD. In the presence of LY 367385 plusMPEP, the peak ampli-
tude of MF-GPSCs reached 65 6 7.3% of control values (n59;
p50.88; one-way ANOVA; see (see Supplementary Fig. S2 online)
indicating that group I mGluR are not involved. Furthermore, STD-
LTD did not result from an indirect modulation of eCBs by receptors
that depress transmitter release such as GABAB, nicotine and mus-
carinic acetylcholine receptors, purinergic P2Y and adenosine recep-
tors since the pairing procedure still induced STD-LTD in the
presence of the respective antagonists (see Supplementary Fig. S2
online).
Anandamide and 2-arachidonylglycerol (2-AG) are well studied
endogenous ligands at cannabinoid receptors8. In order to identify
which of these two molecules is involved in STD-LTD, the post-
synaptic cell was loaded with THL, an inhibitor of diacylglycerol
lipase activity15,16. THL did not affect STD-LTD: pairing postsynaptic
spikingwith presynapticMF stimulation reduced the peak amplitude
ofMF-GPSCs to 596 8% as in the absence of the drug (n59; p50.03;
paired t-test; see Supplementary Fig. S3 online). The depressant
effect was not significantly different from that obtained in the
absence of THL (p50.76; one-way ANOVA). THL failed to block
STD-LTD also when it was applied in the bath at the concentration of
10 mM; 20 min after pairing, the peak amplitude of GPSCs was 51.7
6 0.12% of controls; n55; p,0.05; paired t-test; data not shown).
These data suggest that 2-AG is not involved in STD-LTD.
To further investigate the endogenous eCB ligand involved in
STD-LTD, we next used drugs that alter endocannabinoids degra-
dation. In the brain, anandamide is metabolized by the fatty acid
amide hydrolase (FAAH)17. Inhibition of FAAH with URB597 (1
mM) did not modify basic synaptic transmission or change the
magnitude of STD-LTD. In the presence of URB597, the pairing
procedure reduced the peak amplitude of MF-GPSCs to 62 6 5%
of controls (n57; p,0.05; paired t-test). However, URB597
lengthened up to 100 ms the time window (between postsynaptic
spiking and presynaptic stimulation) necessary for the induction
of STD-LTD (Fig. 4; see also12). Pairing with a delay of 100 ms
reduced the peak amplitude of GPSCs to 58 6 7% of controls
(n59; p50.03; paired t-test). A further prolongation of the delay
between post and presynaptic stimulation to 200 ms failed to
induce STD-LTD (99.7 6 1.2% of control; n55; p50.5; paired
t-test). Similar data were obtained with AM40417 (10 mM) which
inhibits the carrier responsible for anandamide internalization and
degradation (Fig. 4). In contrast, JZL 184 (1 mM), which increases
the levels of 2-AG by blocking monoacylglycerol lipase, the
enzyme responsible for 2AG degradation, did not alter the time
window for LTD induction (Fig. 4). These data show that limiting
the uptake or the degradation of anandamide prolongs the time
window for the induction of STD-LTD, whereas inhibition of
synthesis or degradation of 2-AG does not alter this form of
synaptic plasticity. Therefore, these results suggest that ananda-
mide is the main mediator of STD-LTD.
If STD-LTD is mediated by CB1 receptors, CB1 agonists should be
able to occlude this form of synaptic plasticity. Overall, in 17 neu-
rons, the CB1 receptor agonist WIN 55,212-2 (2 mM) reduced the
peak amplitude of GPSCs to 69 6 5% of controls (p50.003; Fig. 5D).
These data include also 5 neurons in which WIN 55,212-2 was inef-
fective. In 12/17 neurons (70.5 %) WIN 55,212-2 reduced the peak
amplitude of GPSCs to 57.1 6 3.4% of controls (p,0.001; paired t-
test; Fig. 5A and C). WIN 55,212-2 depressed MF-GPSCs by redu-
cing the probability of GABA release from MF terminals since it
decreased the inverse square of CV and increased the PPR, which
is inversely correlated with release probability18 (see Supplementary
Fig. S4 online). Importantly, when the pairing protocol was applied
after WIN 55,212-2, no further depression of GPSCs was obtained,
indicating occlusion (Fig. 5A and C). However, these experiments
should be interpreted with caution in view of the reported effects of
WIN 55,212-2 on presynaptic calcium channels19. Furthermore,
STD-LTD induction occluded all effects of WIN 55,212-2 (Fig. 5B
and C). Similarly, anandamide (AEA, 30 mM) reduced in 9/13 neu-
rons GPSCs amplitude. The depression of GPSCs amplitude
obtained in all cells tested (included those not affected by AEA)
was 69.5 6 5.6 % of controls (n513; p50.01; Fig. 5D). In 69.2% of
neurons AEA depressed the peak amplitude of GPSCs to 43.3 6 3%
of controls (n59; p50.004), an effect that was blocked by AM251
(n510; p50.31; paired t-test; Fig. 5D), further indicating that ana-
ndamide acts on CB1 receptors. Occlusion was also found between
the depressant effects of AEA on GPSCs and STD-LTD (n55; data
not shown). As expected for eCB-induced synaptic depression, a
partial recovery of GPSCs amplitude towards pre-drug values (to
76.7 6 9.4% of control; n55) was obtained when the CB1 antagonist
AM251 was applied 15 minutes after WIN (data not shown).
In the developing hippocampus, CB1-dependent heterosynaptic
LTD observed in the CA1 region is associated with a decrease in
presynaptic fibres excitability20. We asked whether eCBs may affect
axonal excitability, by recording antidromic spikes from single granule
cells held at 270 mV in the absence or in the presence of the CB1
receptor agonist WIN 55,212-2. MFs were stimulated via an electrode
positioned in stratum lucidum and the stimulus strength was adjusted
to evoke antidromic spikes in . 60% of trials. WIN 55,212-2 (2 mM)
reduced the probability of evoking antidromic spikes to 54.6 6 5.7%
of controls (n57; p,0.001; paired t-test; Fig. 6), indicating that
Figure 3 | Lack of STD-LTD in CB1-KO mice. (A) MF-GPSCs evoked
before, after pairing, after addition of LCCG1 or LCCG1 plus PTX, in WT
mice (open circle, Control) or in CB1-KO mice (closed circle).
(B) Summary plot of mean MF-GPSCs amplitude (before and after
pairing, arrows at time 0) versus time in WT (open circles; n59) or in
CB1-/- mice (closed circles; n510). Data from WT animals are pooled
between those exhibiting (n59) or not (n54) LTD.
www.nature.com/scientificreports
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activation of CB1 receptors probably located onMF terminals reduces
MF excitability. This effect was blocked by AM 251 (Fig. 6).
It is well known that CB1 receptors are not expressed on juve-
nile glutamatergic MF terminals16,21,22. Therefore, in the following
experiments we tested whether the same pairing protocol used in
neonates can induce CB1-dependent STD-LTD at MF-evoked glu-
tamatergic excitatory postsynaptic currents (EPSCs) in CA3 prin-
cipal cells of P19–P25 old animals. These experiments were routinely
performed in the presence of picrotoxin (100 mM) to block GABAA
receptors. Consistent with their MF origin, EPSCs were highly sens-
itive to group II mGluR agonist DCG-IV23. At the concentration of 4
mM this compound induced a 75.8 6 2.1% reduction in the peak
amplitude of EPSCs (Fig. 7). As shown in Fig. 7, negative pairing
(post before pre) failed to modify synaptic strength in all neurons
tested (n519; from 6 rats). After pairing the EPSCs amplitude was
104 6 7% of controls (p50.84; paired t-test).
Our electrophysiological data support the assumption that CB1
receptors are only transiently expressed on MF terminals in the
immediate postnatal period. To validate this hypothesis in situ
hybridization (ISH) experiments were performed from granule cells
at P3 and P21 to assess whether CB1 mRNA expression follows a
similar developmental profile. In the hippocampus of adult mice,
Figure 4 | Blocking anandamide degradation lengthens the time window for STD-LTD induction. (A) MF-GPSCs obtained in control, in the presence
of the FAAH inhibitor URB597 (1 mM), of the carrier inhibitor responsible for anandamide internalization and degradation AM404 (10 mM) and of the
monoacylglicerol lipase inhibitor JZL 184 (1 mM), the enzyme responsible for 2AG degradation, at Dt of 50 and 100 ms. Calibration: 10 ms and 50 pA.
(B) Summary plot of MF-GPSCs obtained in control (n 5 44, 5 and 5), in the presence of URB597 (n57, 9 and 5), AM404 (n55, 7 and 5) or JZL 184
(n56, 15) at different time windows (Dt) between postsynaptic spiking and presynaptic stimulation. Note that while URB597 and AM404 prolonged the
time windows for inducing STD-LTD, JZL 184 did not.
Figure 5 | CB1 receptor agonists reduce the amplitude of MF-GPSCs.
(A) The depressant effect of WIN 55,212-2 (2 mM, bar) onMF-GPSCs was
occluded by subsequent pairing (arrow, n512). (B) When WIN 55,212-2
(bar) was applied after pairing (arrow) it did not affect MF-GPSCs (n58).
(C) Individual samples (average of 30 to 60 responses including failures)
from A and B respectively. (D)MeanMF-GPSCs amplitude obtained in all
cells tested after application of WIN 55,212-2 (n517), AEA (n513) or
AEA plus AM351 (n510). Note that AM251 completely antagonized the
effects of AEA on MF-GPSCs. **p # 0.01.
Figure 6 | Activation of CB1 receptors with WIN 55,212-2 reduces MF
excitability. (A) Antidromic spikes evoked in granule cells upon
stimulation of MF in stratum lucidum before and during bath application
ofWIN 55,212-2 (note that in this particular case the stimulus strength was
set to obtain 100%of successes). (B) Summary plot for the examples shown
in A (n57). C–D As in A–B but in the presence of AM251 (n5 7);
***p,0.001.
www.nature.com/scientificreports
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CB1 mRNA is detected at very high levels in GABAergic interneur-
ons and at low levels in CA1 and CA3 pyramidal neurons but not in
granule cells21. Interestingly, in the present experiments at P3 granule
cells displayed low, but detectable levels of CB1 mRNA (Fig. 8 A),
which were clearly above background levels as determined in sec-
tions from CB1-KOmice (Fig. 8 A). In line with electrophysiological
data however, this expression was lost at P21 mice (Fig. 8 B). Thus,
granule cells transiently express CB1 mRNA only at early stages of
postnatal development.
Discussion
Both pharmacological (selective CB1 antagonists) andmouse genetic
(CB1-KO mice) data clearly demonstrate that STD-LTD induced by
negative pairing ismediated by activation of Gi/o-coupled CB1 recep-
tors at immature MF-CA3 synapses. Endocannabinoids are phos-
pholipids that are synthesised and released from brain cells to
regulate neuronal activity and synaptic plasticity8,17. Our results show
the induction of STD-LTD is postsynaptic, triggered by calcium
influx via voltage-dependent calcium channels activated by spik-
ing-induced membrane depolarization. Thus, the calcium chelator
BAPTA may interfere with eCBs production to abolish LTD24,25. In
agreement with our data, previous studies have demonstrated that,
the developmentally regulated expression of eCB-dependent long-
term reduction of glutamate release in different brain regions relies
on postsynaptic mechanisms including calcium rise via VDCC26,27.
Our results exclude the contribution of many G protein-coupled
receptors known to stimulate eCB production in other contexts9
since STD-LTD was preserved in the presence of specific receptor
antagonists.
Anandamide and 2-AG are endocannabinoids known to regu-
late synaptic transmission mainly through presynaptic CB1 recep-
tors17. While 2-AG seems to be rather specific for CB1 receptors,
anandamide binds to both CB1 and vanilloid type 1 (TRPV1)
receptors28. At inhibitory synapses, 2-AG has been proposed to
mediate different forms of long- and short-term synaptic plas-
ticity, which are affected by specific inhibitors of synthesis, uptake
or degradation of this endocannabinoid8,9. However, the other
major endocannabinoid has also been proposed to mediate differ-
ent forms of synaptic plasticity, such as LTD at excitatory
synapses in the basal ganglia27 or LTD at inhibitory synapses in
the amygdala29. Our data strongly suggest that 2-AG is not
involved in STD-LTD, since blockade of 2AG synthesis (by intra-
cellular and bath-applied THL) or degradation (by JZL 184) did
not affect pairing-induced synaptic depression. Several lines of
evidence support instead the involvement of anandamide in
STD-LTD. Thus, inhibiting anandamide transport with AM40430
or its degradation with URB59731,32 lengthened the time window
for LTD, suggesting that anandamide is the endogenous ligand
released by principal cells. Anandamide was acting on CB1 and
not TRPV1 receptors since the effects of this molecule on GPSCs
were antagonized by the CB1 receptor antagonist AM251 and the
pairing protocol failed to induce STD-LTD in animals lacking
CB1 receptors. Variation in the rate of eCBs production or inac-
tivation may account for differences in the temporal window for
LTD observed at different synapses12,28. While STD-LTD is
induced postsynaptically, its expression seems to be presynaptic
judged by pairing-induced changes in the number of successes,
1/CV2 and PPR. In particular, analysis of the CV of synaptic
responses indicates a presynaptic expression site presumably
associated with a reduced GABA release10. The suppression of
STD-LTD by CB1 receptor antagonists points to a locus of
expression coinciding with CB1 receptors. Possibly, eCBs are pro-
duced by postsynaptic neurons and diffuse retrogradely to activate
CB1 receptors on MF terminals. Further evidence that CB1 recep-
tors are involved in STD-LTD is given by data showing that the
depressant effects of WIN 55,212-2 or AEA on synaptic currents
were occluded by STD-LTD, indicating that both STD-LTD and
WIN 55,212-2 act on the same targets. As for STD-LTD, the locus
of WIN 55,212-2 and AEA action was clearly presynaptic as sug-
gested by the decrease in CV2 values and the increase in PPR. WIN
55,212-2 may depress GPSCs amplitude by reducing MF excitability,
since it decreased the probability of evoking antidromic spikes.
Changes in fibre excitability due to potassium channel activation
have been implicated in eCB-mediated heterosynaptic depression
at Schaffer collateral-CA1 synapses in developing hippocampus20.
Whatever the mechanisms, our work clearly suggests that, early in
postnatal life, CB1 receptors are expressed on the axons of cells
projecting from the granule cell layer to stratum lucidum.
Previous reports failed to show the presence of CB1 receptors on
adult glutamatergic MF terminals16,22 or CB1mRNA in adult granule
Figure 7 | Lack of CB1-mediated STD-LTD in hippocampal slices
obtained from P19–P25 old rats. (A) Glutamatergic MF-EPSCs evoked in
the presence of picrotoxin (100 mM) before (Control), after pairing, after
addition of DCG-IV or DCG-IV plus DNQX. The inset above the traces
shows paired pulse facilitation of MF-EPSCs. (B) Mean amplitude of MF-
EPSCs before and after pairing (arrows at time 0) versus time (n519). Note
that pairing did not affect synaptic responses. These were strongly reduced
by DCG-IV and blocked by DNQX.
Figure 8 | Developmentally-regulated expression of CB1 mRNA in the
granule cell layer of the dentate gyrus. (A) and (B) On the left,
photomicrographs representing CB1 mRNA staining (red) alone or
together with DAPI nuclear counterstaining (blue) in the dentate gyrus of
WT and CB1-KO mice at P3 (A) and at P21 (B) animals. Cal. bar: 20 mm.
On the right, Each column represents the averaged value of CB1 mRNA
expression obtained in 4-8 sections corresponding to dorsal DG of WT or
CB1-KO mice at P3 and at P21 (2 mice per group; see methods).
***p,0.001.
www.nature.com/scientificreports
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cells21 and in agreement with these findings we failed to induce CB1-
mediated STD-LTD at glutamatergic MF-CA3 synapses in the hip-
pocampus of juvenile animals, using the same protocol of neonates.
However, it is worth noting that a NMDA-dependent form of STD-
LTD can be induced at these synapses using a different stimulating
paradigm23.
Consistent with the involvement of endocannabinoid signalling
at immature MF-CA3 synapses, in situ hybridization experiments
revealed clearly detectable levels of CB1 mRNA in the granule cell
layer of the hippocampus of P3 old animals. In older animals instead,
the expression of CB1 mRNA was drastically reduced (if not absent;
see also Ref 21), suggesting that in this area CB1 expression is devel-
opmentally regulated. Although we cannot exclude that, at P3, cells
more strongly labelled belongs to GABAergic interneurons, their
involvement in STD-LTD seems unlikely since all neurons tested
were severely depressed by L-AP4 or LCCG1while GABAergic inter-
neurons are usually not sensitive to mGluR agonists2,33. In addition,
the reduced probability of evoking antidromic spikes in granule cells
exposed toWIN 55,212-2, a selective CB1 agonist, suggests that CB1
receptors are expressed on cells projecting from the granule cell layer
to the stratum lucidum. Whether stimulated axons originate from
granule cells or progenitors expressing a GABAergic phenotype is
still a matter of debate2,34. Alternatively, we cannot exclude the pos-
sibility that anandamide binds to CB1 receptors present on different
cell types (i.e. astrocytes) whose activation may modulate GABA
release from MF terminals. It is know that early in postnatal life
GABA can be released in a calcium- and SNARE-independent way
by non-conventional release sites such as growth cones and astro-
cytes and can diffuse away to activate in a paracrine fashion extra-
synaptic receptors35.
What could be the functional role of eCBs-mediated STD-LTD at
immatureGABAergicMF-CA3 synapses? During postnatal develop-
ment, activity-dependent changes in synaptic strength are thought to
be involved in the refinement of neuronal circuits6,36. At early devel-
opmental stages eCBs are known to be present, especially in brain
areas that control movements, cognition and attention as well as
emotion and memory37–39. During gestation, CB1 receptors are
enriched in axonal growth cones of cortical GABAergic interneurons
where they contribute to regulate axonal guidance, selective targeting
and synaptogenesis40. During postnatal development, changes in
CB1 receptor expressionmay underlie the age-dependent magnitude
of eCB-mediated i-LTD an effect that parallels the sensitivity of
GABAergic41 and glutamatergic42 neurotransmission to eCBs. Also
at Schaffer collateral-CA1 synapses, the heterosynaptic eCB-mediated
persistent depression of glutamate release observed immediately after
birth disappears in the mature hippocampus20. Our data suggest that
in early postnatal life, eCBs counter the excitatory actions of glutam-
ate and GABA, thus preventing at the network level neuronal hyper-
excitability.
Methods
Slice preparation.All experiments were carried out in accordance with the European
Community Council Directive of 24 November 1986 (86/609EEC) and were
approved by local veterinary authorities (Dr. Giuseppe Stradaioli). All efforts were
made to minimize animal suffering and to reduce the number of animal used.
Experiments were performed on hippocampal slices from P3–P6 and P19–P25 old
Wistar rats, and from CB1-KO mice and WT littermate43 of the same postnatal age,
following a method already described by Gasparini et al.44. Briefly, animals were
decapitated after being anaesthetized with an i.p. injection of urethane (2 g/kg). The
brain was quickly removed from the skull and placed in ice-cold ACSF containing (in
mM): NaCl 130, KCl 3.5, NaH2PO4 1.2, NaHCO3 27, MgCl2 1.3, CaCl2 2, glucose 25,
saturated with 95%O2 and 5%CO2 (pH 7.3–7.4). Transverse hippocampal slices (400
mm thick) were cut with a vibratome and stored at room temperature (20–24uC) in a
holding bath containing the same solution as above. After recovering for at least one
hour, single slices were transferred to a recording chamber where they were
superfused with oxygenated ACSF at a rate of 2–3 ml/min at 33–35uC.
Electrophysiological recordings. Recordings were made from CA3 pyramidal cells
using the whole-cell patch-clamp configuration in current or voltage-clamp mode.
Neurons were visualized using an upright microscope (Olympus BX51WI) equipped
with differential interference contrast optics and infrared video camera. Patch
electrodes were pulled from borosilicate glass capillaries (Hingelberg, Malsfeld, D).
They had a resistance of 4–6 MVwhen filled with an intracellular solution containing
(in mM): KCl 140, MgCl2 1, HEPES 10, MgATP 4, EGTA 0.5 (pH 7.3). In some
experiments, recordings were performed with patch pipettes containing the calcium
chelator 1,2-bis (2-aminophenoxy) ethane-N,N,N’,N’-tetraacetic acid (BAPTA
20 mM, purchased from Sigma, Milan, Italy). In these cases, the KCl pipette
concentration was reduced to 120 mM to maintain osmolarity at ,290 mOsm.
Recordings were made with a patch clamp amplifier (Axopatch 1D; Axon
Instruments, Foster City, CA). Series resistance was assessed repetitively every five
min and in current-clamp recordings compensated at 75% throughout the
experiment. Cells exhibiting more than 15–20% changes in series resistance were not
analyzed.
GABAA-mediated synaptic potentials or currents (GPSPs or GPSCs) were evoked
at 0.05 Hz from a holding potential of 260 mV in the presence of DNQX (50 mM)
and D-AP5 (50 mM) to block AMPA- and NMDA-mediated synaptic responses,
respectively. We stimulated granule cells minimally in the dentate gyrus45,46.
Stimulation intensity was decreased until a single axon may have been activated. We
judged that a single fibre terminating on the recorded cell was activated when the
mean postsynaptic current amplitude and failure probability remained constant over
a range of stimulus intensities near threshold for detecting a response2. An abrupt
increase in the mean peak amplitude of synaptic currents was observed when the
stimulus intensity was further increased. This all or none behaviour and the constant
latency and shape of individual synaptic responses over time let us assume that only a
single fibre was stimulated. The monosynaptic nature of synaptic currents was sup-
ported by unimodal and narrow distributions of latency and rise timewhich remained
constant when the extracellular Ca21/Mg21 concentration ratio was reduced from
251.3 to 1532.
MF inputs were identified on the basis of their sensitivity to the group II and III
mGluR agonists 2-amino-4-phosphonobutyric acid (L-AP4), 2S,l9S,29S)-2-(29-car-
boxycyclopropyl)glycine (L-CCG) or dicarboxycyclopro pyl)glycine (DCG-IV), their
strong paired pulse facilitation and short-term frequency-dependent facilitation2. In
neonates,MF-mediated synaptic responses were blocked by bicuculline or picrotoxin,
confirming their GABAergic nature. In contrast to MF inputs, GABAergic inputs
from interneurons were insensitive to mGluR agonists2,33.
STD-LTD was induced in current clampmode by pairing postsynaptic spikes with
MF stimulation. MF-GPSCs were recorded first in voltage clamp mode for 5–10 min
to obtain a stable baseline. Then a sequence of postsynaptic spike-MF stimulation was
repeated ten times at 0.1 Hz with a delay of 50 ms (in some cases also with a delay of
100 and 200 ms) between postsynaptic spiking and presynaptic MF stimulation.
Changes in synaptic efficacy were monitored by recording synaptic currents for
additional 20–30 min after pairing.
In some experiments, antidromic action potentials were recorded from visually
identified granule cells in dentate gyrus. In this case the intracellular solution con-
tained K-gluconate (150 mM) instead of KCl. Extracellular stimuli (at 0.3 Hz,
duration 150 ms) were delivered via a stimulation electrode positioned in stratum
lucidum , 200 mm away from the granule cell layer.
Drugs used were: N-(Piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-
methyl-1H-pyrazole-3-carboxamide (AM251), N-(4-Hydroxyphenyl)-
5Z,8Z,11Z,14Z-eicosatetraenamide (AM404), N-(2-Hydroxyethyl)-5Z,8Z,11Z,14Z-
eicosatetraenamide (Anandamide, AEA), atropine, 3-[[(3,4-dichlorophenyl)
methyl]amino]propyl]diethoxymethyl)phosphinic acid (CGP 52432), D-(-)-2-
amino-5-phosphonopentaoic acid (D-AP5), dihydro-b-erythroidine (DHbE), 6,7-
dinitroquinoxaline-2,3-dione (DNQX), 8-Cyclopentyl-1,3-dipropylxanthine
(DPCPX), L(1)-2-amino-4-phosphonobutyric acid (L-AP4), dicarboxycyclopro
pyl)glycine (DCG-IV), 2S,l9S,29S)-2-(29-carboxycyclopropyl)glycine (L-CCGl), (2S)-
2-amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl)propanoic acid
(LY367385), 2-Methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP), nifedi-
pine, picrotoxin (PTX), tetrahydrolipstatin (THL), R)-(1)-[2,3-Dihydro-5-methyl-
3-(4-orpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl-
methanone mesylate (WIN 55,212-2 mesylate), (all purchased from Tocris Cookson
Ltd, Bristol, UK); 4-[[4-formyl-5-hydroxy-6-methyl-3-[(phosphonooxy)methyl]-
2pyridinyl] azo]-1,3-benzenedisulfonic acid tetrasodium salt (PPADS), (from Sigma,
Milan, Italy); 4-nitrophenyl-4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperi-
dine-1-carboxylate (JZL 184), (39-(aminocarbonyl)[1,19-biphenyl]-3-yl)-cyclohex-
ylcarbamate (URB597) from Cayman Chemicals. All drugs were dissolved in either
distilled water or ethanol, as required, except DNQX, WIN 55,212-2 mesylate,
AM251 andURB597whichwere dissolved in dimethylsulphoxide (DMSO). The final
concentration of DMSO in the bathing solution was 0.1%. At this concentration,
DMSO alone did not modify the shape or the kinetics of synaptic currents. Drugs
were applied by changing the bath superfusion solution via a three-way tap system.
Complete exchange was obtained within 1–2 min.
Data acquisition and analysis. Data were acquired and digitized with an A/D
converter (Digidata 1200, Molecular Devices) and stored on a computer hard disk.
Acquisition and analysis of evoked responses were performed with Clampfit 9
(Molecular Devices). Data were sampled at 20 kHz and filtered with a cut off
frequency of 1 kHz.MeanGPSCs amplitude was obtained by averaging successes and
failures. The paired pulse ratio (PPR) was calculated as the mean amplitude of the
synaptic response evoked by the second stimulus over that evoked by the first one.
The coefficient of variation was calculated as the ratio of the standard deviation and
the mean synaptic current amplitude. Unless otherwise stated, data are presented as
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 285 | DOI: 10.1038/srep00285 6
mean 6 SEM. Statistical analysis was done using either Student’s paired t-test for
single comparisons or one-way ANOVA for multiple comparisons. A p value, 0.05
was considered statistically significant.
Fluorescent in situ hybridization (ISH). The brains of P3 and P21 null CB1 mutant
mice and wild-type littermates were isolated, quickly frozen on dry ice and stored at
280u C until sectioning in a cryostat (14 mm, Microm HM 500 M, Microm
Microtech, France). ADIG-labelled riboprobe againstmouse CB1 receptorwas used21
and procedures were as previously described using the TSA amplification System47.
Slides were analyzed by epifluorescencemicroscopy at 20X (Leica) and photographed
using a Coolsnap HQ2 camera (Roper). In order to detect low but specific levels of
labelling, the acquisition parameters were chosen using CB1-KO sections in order to
exclude any background signal and exactly the same parameters were immediately
used to acquire the images fromwild-type P3 and P21 sections. Images of CB1mRNA
labelling did not undergo any post-acquisition processing.
Images of CB1 mRNA FISH were acquired in epifluorescence and the levels of
expression were evaluated using the program Image J on 4–8 sections corresponding
to dorsal DG of wild-type and CB1-KO P3 and P21 mice (2 mice per group). The
levels of fluorescent signal weremeasured by pixel intensity in black and white images
after background subtraction for each section (same parameters for all samples). Six
regions of interest were randomly chosen for each section corresponding to the
granule cell layer of the dentate gyrus, with the only limit to avoid brightly stained
cells, presumably corresponding to GABAergic interneurons21. The average values of
each section represented one data point. Values were also obtained in a similar way
from P3 and P21 CB1-KO mice.
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